GEVA
Capital Research Global Investors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-4,527,358
| Closed | -$442M | – | 462 |
|
|
2015
Q1 | $442M | Buy |
4,527,358
+458,100
| +11% | +$44.7M | 0.15% | 142 |
|
|
2014
Q4 | $378M | Buy |
4,069,258
+6,486
| +0.2% | +$602K | 0.13% | 175 |
|
|
2014
Q3 | $279M | Buy |
4,062,772
+18,011
| +0.4% | +$1.24M | 0.1% | 197 |
|
|
2014
Q2 | $424M | Buy |
4,044,761
+10,124
| +0.3% | +$1.06M | 0.15% | 144 |
|
|
2014
Q1 | $335M | Buy |
4,034,637
+269,214
| +7% | +$22.3M | 0.12% | 170 |
|
|
2013
Q4 | $244M | Buy |
3,765,423
+249,651
| +7% | +$16.2M | 0.09% | 199 |
|
|
2013
Q3 | $223M | Buy |
3,515,772
+193,970
| +6% | +$12.3M | 0.09% | 206 |
|
|
2013
Q2 | $140M | Buy |
+3,321,802
| New | +$140M | 0.06% | 238 |
|